Cartesian Therapeutics
RNAC
#7523
Rank
C$0.41 B
Marketcap
$15.92
Share price
11.28%
Change (1 day)
-10.78%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -C$0.11 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are C$38.91 Million. , an increase over its 2023 earnings that were of -C$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.11 Billion-67.3%
2023 -C$0.34 Billion-724%
2022 C$53.5 M-649.67%
2021 -C$9.74 Million-89.78%
2020 -C$95.3 Million25.06%
2019 -C$76.21 Million-15.68%
2018 -C$90.38 Million-0.43%
2017 -C$90.76 Million83.41%
2016 -C$49.49 Million44.3%
2015 -C$34.3 Million